Companies / Candel Therapeutics, Inc.

Candel Therapeutics, Inc.

Nasdaq: CADLCIK 1841387NEEDHAM, MA

Financials · FY2022

Revenue$125.0K
Net income$-38.18M
Total debt$1.73M
Cash$201.56M
Diluted EPS$-0.72
Shares outstanding76.5M

Ownership

76.5M shares outstanding · as of Aug 6, 2026
3.6%Insiders
Ownership
Insiders3.61%2,763,527
10%+ / strategic3.74%2,859,610
Institutions35.45%27,128,269
Public float57.20%43,767,159

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Paul B ManningDirector
3.61%2,763,527
Barone FrancescaChief Scientific Officer
——
Nichols William GarrettChief Medical Officer
——
Papa Joseph CDirector
——
Schoch CharlesChief Financial Officer
——
Tak Paul PeterCEOChief Executive Officer · Director
——
Tyagarajan SeshuChief Technology Officer
——

Institutional holders 96

View all →
HolderValue% of shares
BlackRock, Inc.$51.18M6.49%
Fmr LLC$46.52M10.76%
State Street Corporation$36.56M4.64%
Acorn Capital Advisors, LLC$14.58M3.37%
Portolan Capital Management, LLC$14.18M3.78%
Vanguard Group Inc$13.02M3.01%
Millennium Management LLC$5.19M1.39%
Geode Capital Management, LLC$5.07M1.35%
Halter Ferguson Financial Inc.$4.23M0.98%
Heights Capital Management, Inc$3.80M1.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 23, 2026Paul B Manning
Director
BuyCommon Stock$3.00M+550K
+24.87%
2,763,527
3.61% of shares
high
Jun 23, 2026Papa Joseph C
Director
GrantStock Option (Right to Buy)—+32K
32,000
0.04% of shares
low
Mar 31, 2026Papa Joseph C
Director
GrantStock Option (Right to Buy)—+3K
2,795
<0.01% of shares
low
Jan 26, 2026Tyagarajan Seshu
Executive
GrantStock Option (Right to Buy)—+154K
154,000
0.20% of shares
low
Jan 26, 2026Nichols William Garrett
Executive
GrantStock Option (Right to Buy)—+137K
136,500
0.18% of shares
low
Jan 26, 2026Schoch Charles
Executive
GrantStock Option (Right to Buy)—+232K
232,000
0.30% of shares
low
Jan 26, 2026Tak Paul Peter
CEO
GrantStock Option (Right to Buy)—+629K
629,000
0.82% of shares
low
Jan 26, 2026Barone Francesca
Executive
GrantStock Option (Right to Buy)—+232K
232,000
0.30% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
BlackRock, Inc.Passive13G—2,859,610—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CADLCommon StockEquity137404109BBG00N0D4Z71